Part I: Key concepts in infectious disease research
An overview of key concepts, introducing some of the challenges in estimating the burden of infectious disease.
I’m a Research Associate at the MRC Biostatistics Unit in Cambridge. My PhD focussed on applications of multi-state models to estimate infectious disease burden, specifically HIV and COVID-19. My current research involves the development of multi-state “back-calculation” models to estimate HIV incidence and undiagnosed HIV prevalence.

This series of blog posts provides an introduction to statistical methods for survival data, with applications for infectious disease modelling and epidemiology. Topics include: classical survival methods, competing risks analysis, and causal inference from observational data.
2024
Protection of vaccine boosters and prior infection against mild/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024. Journal of Infection.
2024
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort. The Lancet Regional Health - Europe.
2022
Re-assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing. HIV Medicine.
2022
Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study. Nature Communications.
Full list of publications (via Google Scholar).
2024
Multi-state modelling to estimate infectious disease burden. University of Cambridge, UK.
Feel free to reach out about research collaborations, speaking opportunities, or general enquiries:
📧 pdk29 [at] cam [dot] ac [dot] uk